An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma
Clinical trial NCT03068455 · COMPLETED
Trial details
- NCT number
- NCT03068455
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-11
- Primary completion
- 2020-06-12
- Enrollment
- 1844
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.